Acetylsalicylic acid (ASA)

Acetylsalicylic acid (ASA)


Acetylsalicylic acid (ASA), often marketed as aspirin, is a medication used to relieve pain, fever, or inflammation. Specific inflammatory conditions for which aspirin is used include Kawasaki disease, pericarditis, and rheumatic fever. Aspirin given shortly after a heart attack reduces the risk of death. Aspirin is also used long-term to prevent further heart attacks, ischemic strokes, and blood clots in people at high risk. It may also reduce the risk of certain cancers, especially colorectal cancer. It typically takes effect within 30 minutes for pain or fever. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) and works similarly to other NSAIDs but also suppresses normal platelet function.

Drugs with Acetylsalicylic acid (ASA)

Drug Substance(s) Authorisation holder
Clopidogrel TAD 75 mg film-coated tablets Acetylsalicylic acid (ASA) TAD Pharma GmbH
Clopidogrel Qualimed 75 mg film-coated tablets Acetylsalicylic acid (ASA) Qualimed



Acetylsalicylic acid (ASA) blocks prostaglandin synthesis. It is non-selective for the enzymes COX-1 and COX-2, and inhibition of these enzymes results in inhibition of platelet aggregation for approximately 7-10 days (average platelet lifespan). The acetyl group of acetylsalicylic acid binds to a serine residue of the enzyme cyclooxygenase-1 (COX-1), resulting in irreversible inhibition. This prevents the production of the prostaglandins that cause pain. This process also stops the conversion of arachidonic acid to thromboxane A2 (TXA2), which is a potent trigger for platelet aggregation. Platelet aggregation can lead to clots and harmful venous and arterial thromboembolism, resulting in conditions such as pulmonary embolism and stroke.


Absorption is generally rapid and complete following oral administration, but may vary widely depending on route of administration. 50% to 90% of a normal therapeutic concentration of salicylate (a major metabolite of acetylsalicylic acid) binds to plasma proteins, particularly albumin. Acetylsalicylic acid is hydrolyzed to salicylic acid in plasma and then further metabolized in the liver. Excretion of salicylates (metabolites of ASA) is mainly by the kidney.

Drug Interactions

Acetylsalicylic acid may interact with other drugs. Aspirin is known to displace a number of drugs from protein binding sites in the blood, including the antidiabetic drugs tolbutamide and chlorpropamide, warfarin, methotrexate, phenytoin, probenecid, valproic acid (as well as beta-oxidation, an important part of valproate metabolism), and other NSAIDs. This increases the plasma concentration of the aforementioned drugs and thus may lead to adverse side effects.

Corticosteroids may decrease the concentration of aspirin. Ibuprofen may abolish the antiplatelet effect of aspirin, which is used for cardioprotection and stroke prevention.

The pharmacologic activity of spironolactone may be decreased by aspirin ingestion, and it is known to compete with penicillin G for renal tubular secretion. Aspirin may also inhibit the absorption of vitamin C.


Side effects

Common adverse effects often involve the gastrointestinal tract.

More serious side effects include stomach ulcers, stomach bleeding, and exacerbation of asthma. The risk of bleeding is greater in people who are older, drink alcohol, take other NSAIDs, or take other blood thinners. Use of acetylsalicylic acid is not recommended during the last trimester of pregnancy. High doses may cause ringing in the ears.

Toxicological Data

LD50 (rat, oral): 200 mg-kg-1

Chemical & physical properties

ATC Code A01AD05, B01AC06, N02BA01
Formula C9H8O4
Molar Mass (g·mol−1) 180,16
Physical State solid
Density (g·cm−3) 1,35
Melting Point (°C) 136
PKS Value 3,49
CAS Number 50-78-2
PUB Number 2244
Drugbank ID DB00945


  • Drugbank
  • PubChem
  • Aktories, Förstermann, Hofmann, Starke: Allgemeine und spezielle Pharmakologie und Toxikologie, Elsvier, 2017

Editorial principles

All information used for the content comes from verified sources (recognised institutions, experts, studies by renowned universities). We attach great importance to the qualification of the authors and the scientific background of the information. Thus, we ensure that our research is based on scientific findings.
Markus Falkenstätter, BSc

Markus Falkenstätter, BSc

Markus Falkenstätter is a writer on pharmaceutical topics in Medikamio's medical editorial team. He is in the last semester of his pharmacy studies at the University of Vienna and loves scientific work in the field of natural sciences.

Mag. pharm. Stefanie Lehenauer

Mag. pharm. Stefanie Lehenauer

Stefanie Lehenauer has been a freelance writer for Medikamio since 2020 and studied pharmacy at the University of Vienna. She works as a pharmacist in Vienna and her passion is herbal medicines and their effects.

The content of this page is an automated and high-quality translation from DeepL. You can find the original content in German here.


Your personal medicine assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über medikamio GmbH & Co KG und sein/ihr Internet-Angebot: This website is certified by Health On the Net Foundation. Click to verify.

Search our database for drugs, sorted from A-Z with their effects and ingredients.


All substances with their common uses, chemical components and medical products which contain them.


Causes, symptoms and treatment for the most common diseases and injuries.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.